1. Home
  2. RGEN vs BYD Comparison

RGEN vs BYD Comparison

Compare RGEN & BYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • BYD
  • Stock Information
  • Founded
  • RGEN 1981
  • BYD 1973
  • Country
  • RGEN United States
  • BYD United States
  • Employees
  • RGEN N/A
  • BYD N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • BYD Hotels/Resorts
  • Sector
  • RGEN Health Care
  • BYD Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • BYD Nasdaq
  • Market Cap
  • RGEN 7.6B
  • BYD 6.5B
  • IPO Year
  • RGEN N/A
  • BYD 1993
  • Fundamental
  • Price
  • RGEN $160.51
  • BYD $74.88
  • Analyst Decision
  • RGEN Buy
  • BYD Buy
  • Analyst Count
  • RGEN 12
  • BYD 16
  • Target Price
  • RGEN $187.44
  • BYD $92.27
  • AVG Volume (30 Days)
  • RGEN 521.6K
  • BYD 876.2K
  • Earning Date
  • RGEN 02-19-2025
  • BYD 02-06-2025
  • Dividend Yield
  • RGEN N/A
  • BYD 0.91%
  • EPS Growth
  • RGEN N/A
  • BYD N/A
  • EPS
  • RGEN N/A
  • BYD 5.22
  • Revenue
  • RGEN $633,513,000.00
  • BYD $3,843,691,000.00
  • Revenue This Year
  • RGEN $2.28
  • BYD $5.23
  • Revenue Next Year
  • RGEN $9.88
  • BYD $0.89
  • P/E Ratio
  • RGEN N/A
  • BYD $14.35
  • Revenue Growth
  • RGEN N/A
  • BYD 3.69
  • 52 Week Low
  • RGEN $113.50
  • BYD $49.34
  • 52 Week High
  • RGEN $211.13
  • BYD $76.73
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 62.61
  • BYD 61.77
  • Support Level
  • RGEN $150.23
  • BYD $70.00
  • Resistance Level
  • RGEN $160.64
  • BYD $74.41
  • Average True Range (ATR)
  • RGEN 6.76
  • BYD 1.45
  • MACD
  • RGEN 1.14
  • BYD 0.23
  • Stochastic Oscillator
  • RGEN 80.27
  • BYD 78.46

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About BYD Boyd Gaming Corporation

Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.

Share on Social Networks: